BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10616914)

  • 1. Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats.
    Hida H; Hashimoto M; Fujimoto I; Nakajima K; Shimano Y; Nagatsu T; Mikoshiba K; Nishino H
    Neurosci Res; 1999 Nov; 35(2):101-12. PubMed ID: 10616914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.
    Lundberg C; Horellou P; Mallet J; Björklund A
    Exp Neurol; 1996 May; 139(1):39-53. PubMed ID: 8635567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.
    Mandel RJ; Rendahl KG; Spratt SK; Snyder RO; Cohen LK; Leff SE
    J Neurosci; 1998 Jun; 18(11):4271-84. PubMed ID: 9592104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
    Horellou P; Vigne E; Castel MN; Barnéoud P; Colin P; Perricaudet M; Delaère P; Mallet J
    Neuroreport; 1994 Dec; 6(1):49-53. PubMed ID: 7703427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease.
    Yoshimoto Y; Lin Q; Collier TJ; Frim DM; Breakefield XO; Bohn MC
    Brain Res; 1995 Sep; 691(1-2):25-36. PubMed ID: 8590062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.
    Corti O; Sánchez-Capelo A; Colin P; Hanoun N; Hamon M; Mallet J
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12120-5. PubMed ID: 10518586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats].
    Tian YY; Sun SG; Wang JN; Tang CJ; Feng Y; Wang L; Chen XW; Qiao X
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(29):2054-9. PubMed ID: 17064552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
    Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
    Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes.
    Ridet JL; Corti O; Pencalet P; Hanoun N; Hamon M; Philippon J; Mallet J
    Hum Gene Ther; 1999 Jan; 10(2):271-80. PubMed ID: 10022551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titer retroviral gene transduction to neural progenitor cells for establishment of donor cells for neural transplantation to parkinsonian model rats.
    Kodama Y; Hida H; Jung CG; Baba H; Isono M; Kobayashi H; Nishino H
    Neurol Med Chir (Tokyo); 2004 Jul; 44(7):344-51; discussion 352. PubMed ID: 15347210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats.
    Hermens WT; Verhaagen J
    Hum Gene Ther; 1997 Jun; 8(9):1049-63. PubMed ID: 9189763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.
    Cederfjäll E; Sahin G; Kirik D; Björklund T
    Mol Ther; 2012 Jul; 20(7):1315-26. PubMed ID: 22294150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
    Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral transplantation and successful integration of astrocytes following genetic modification with a high-capacity adenoviral vector.
    Arnhold S; Kreppel F; Kandirali S; Lenartz D; Klinz FJ; Sturm V; Kochanek S; Andressen C; Addicks K
    Cell Transplant; 2002; 11(7):663-70. PubMed ID: 12518893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum.
    Tornatore C; Baker-Cairns B; Yadid G; Hamilton R; Meyers K; Atwood W; Cummins A; Tanner V; Major E
    Cell Transplant; 1996; 5(2):145-63. PubMed ID: 8689028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum.
    Cunningham LA; Hansen JT; Short MP; Bohn MC
    Brain Res; 1991 Oct; 561(2):192-202. PubMed ID: 1686984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental parkinsonism.
    Cortez N; Trejo F; Vergara P; Segovia J
    J Neurosci Res; 2000 Jan; 59(1):39-46. PubMed ID: 10658184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.